David S.C. Hui

83.6k total citations · 14 hit papers
420 papers, 27.9k citations indexed

About

David S.C. Hui is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David S.C. Hui has authored 420 papers receiving a total of 27.9k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Infectious Diseases, 149 papers in Pulmonary and Respiratory Medicine and 120 papers in Epidemiology. Recurrent topics in David S.C. Hui's work include SARS-CoV-2 and COVID-19 Research (89 papers), Respiratory viral infections research (76 papers) and COVID-19 Clinical Research Studies (75 papers). David S.C. Hui is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (89 papers), Respiratory viral infections research (76 papers) and COVID-19 Clinical Research Studies (75 papers). David S.C. Hui collaborates with scholars based in Hong Kong, China and United States. David S.C. Hui's co-authors include Alimuddin Zumla, Fanny W.S. Ko, Joseph J.�Y. Sung, Nelson Lee, Paul K.S. Chan, Susanna S. Ng, Alan Wu, Esam I. Azhar, Stanley Perlman and Kwok‐Yung Yuen and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David S.C. Hui

401 papers receiving 27.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong

2003 1.9k citations Nelson Lee, David S.C. Hui et al. profile →
Coronaviruses — drug discovery and therapeutic options

2016 1.3k citations Alimuddin Zumla, David S.C. Hui et al. profile →
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome

2004 996 citations Chun Kwok Wong, Nelson Lee et al. profile →
Middle East respiratory syndrome

2015 938 citations Alimuddin Zumla, David S.C. Hui et al. profile →
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

2010 834 citations David S.C. Hui et al. profile →
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

2015 505 citations David S.C. Hui et al. profile →
Severe Acute Respiratory Syndrome

2019 363 citations David S.C. Hui, Alimuddin Zumla profile →
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

2022 351 citations Qin Liu, Joyce Wing Yan Mak et al. profile →
Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission

2018 311 citations David S.C. Hui, Alimuddin Zumla et al. profile →
Influenza

2022 281 citations David S.C. Hui et al. profile →
Exhaled air dispersion during high-flow nasal cannula therapyversusCPAPviadifferent masks

2019 217 citations David S.C. Hui, Fanny W.S. Ko et al. profile →
Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccination

2022 211 citations Samuel M. S. Cheng, Chris Ka Pun Mok et al. Nature Medicine profile →
Neutralizing antibody titres in SARS-CoV-2 infections

2021 209 citations Eric H. Y. Lau, Owen TY Tsang et al. Nature Communications profile →
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population

2023 116 citations Samuel M. S. Cheng, Kathy Leung et al. Nature Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
David S.C. Hui	11.1k	6.6k	6.5k	3.8k	3.7k	420	27.9k
Giuseppe Lippi	9.7k 0.9×	8.0k 1.2×	5.1k 0.8×	4.9k 1.3×	9.7k 2.6×	1.7k	53.4k
Paul K.S. Chan	12.8k 1.2×	12.4k 1.9×	2.6k 0.4×	2.2k 0.6×	756 0.2×	603	29.7k
Ying Liu	13.4k 1.2×	2.7k 0.4×	2.3k 0.3×	6.8k 1.8×	926 0.2×	450	24.7k
Mario Plebani	6.1k 0.5×	4.7k 0.7×	3.3k 0.5×	2.2k 0.6×	9.3k 2.5×	1.2k	38.9k
Nanshan Zhong	4.6k 0.4×	1.9k 0.3×	7.0k 1.1×	1.8k 0.5×	4.0k 1.1×	551	18.1k
Bin Cao	15.7k 1.4×	5.7k 0.9×	2.5k 0.4×	7.5k 2.0×	488 0.1×	308	26.7k
Tobias Welte	5.7k 0.5×	10.3k 1.6×	13.5k 2.1×	2.3k 0.6×	3.3k 0.9×	957	35.3k
Susanna Esposito	4.9k 0.4×	10.9k 1.6×	3.8k 0.6×	907 0.2×	1.6k 0.4×	944	24.2k
Yaseen M. Arabi	3.0k 0.3×	5.5k 0.8×	6.5k 1.0×	2.9k 0.8×	1.5k 0.4×	379	20.1k
Yuan Wei	12.8k 1.1×	2.4k 0.4×	1.9k 0.3×	6.4k 1.7×	622 0.2×	246	21.4k

Countries citing papers authored by David S.C. Hui

Since Specialization

Citations

This map shows the geographic impact of David S.C. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S.C. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S.C. Hui more than expected).

Fields of papers citing papers by David S.C. Hui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S.C. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S.C. Hui. The network helps show where David S.C. Hui may publish in the future.

Co-authorship network of co-authors of David S.C. Hui

This figure shows the co-authorship network connecting the top 25 collaborators of David S.C. Hui. A scholar is included among the top collaborators of David S.C. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S.C. Hui. David S.C. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hui, David S.C. & Ka Pang Chan. (2025). Host Immunomodulatory Interventions in Severe Influenza. The Journal of Infectious Diseases. 232(Supplement_3). S262–S272. 5 indexed citations

Chong, Ka Chun, Katherine Min Jia, Christopher Boyer, et al.. (2025). SARS-CoV-2 rebound and post-acute mortality and hospitalization among patients admitted with COVID-19: cohort study. Nature Communications. 16(1). 6924–6924. 2 indexed citations

Cheng, Samuel M. S., et al.. (2024). Cross‐Reactive Antibody Responses to Coronaviruses Elicited by SARS‐CoV‐2 Infection or Vaccination. Influenza and Other Respiratory Viruses. 18(5). e13309–e13309. 3 indexed citations

Costa, Christopher da, Christine Stabell Benn, Thomas Nyirenda, et al.. (2024). Perspectives on development and advancement of new tuberculosis vaccines. International Journal of Infectious Diseases. 141. 106987–106987. 10 indexed citations

Hui, David S.C. & Alimuddin Zumla. (2024). A 5‐year perspective on coronavirus diseases 2019 (COVID‐19). Respirology. 29(11). 937–939. 2 indexed citations

Mok, Chris Ka Pun, Chee Wah Tan, Ka Chun Chong, et al.. (2024). Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine. Journal of Infection. 90(1). 106374–106374. 1 indexed citations

Chen, Zigui, Erik Fung, Chun Kwok Wong, et al.. (2024). Early Metabolomic and Immunologic Biomarkers as Prognostic Indicators for COVID-19. Metabolites. 14(7). 380–380. 2 indexed citations

Yip, Terry Cheuk‐Fung, Grace Lui, Vincent Wai‐Sun Wong, et al.. (2023). Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes. JAMA Network Open. 6(4). e2310887–e2310887. 9 indexed citations

Ling, Lowell, Christopher K.C. Lai, Grace Lui, et al.. (2023). Characterization of upper airway microbiome across severity of COVID-19 during hospitalization and treatment. Frontiers in Cellular and Infection Microbiology. 13. 1205401–1205401. 3 indexed citations

10.

Chan, Ka Pang, Susanna S. Ng, Jenny Ngai, et al.. (2023). Phenotyping empyema by pleural fluid culture results and macroscopic appearance: an 8-year retrospective study. ERJ Open Research. 9(2). 534–2022. 4 indexed citations

11.

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population. Nature Medicine. 29(2). 348–357. 116 indexed citations breakdown →

12.

Wong, Ngai Sze, Shui Shan Lee, Denise Pui Chung Chan, et al.. (2022). Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients. SHILAP Revista de lepidopterología. 2(1). 53–53. 1 indexed citations

13.

Su, Qi, Qin Liu, Lin Zhang, et al.. (2022). Antibiotics and probiotics impact gut antimicrobial resistance gene reservoir in COVID-19 patients. Gut Microbes. 14(1). 2128603–2128603. 10 indexed citations

14.

Tan, Chee Wah, Samuel M. S. Cheng, Haogao Gu, et al.. (2022). Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses. Nature Communications. 13(1). 6285–6285. 3 indexed citations

15.

Mok, Chris Ka Pun, Carolyn A. Cohen, Samuel M. S. Cheng, et al.. (2021). Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong. Respirology. 27(4). 301–310. 91 indexed citations

16.

Perera, Ranawaka A. P. M., Ronald LW Ko, Owen TY Tsang, et al.. (2020). Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera. Journal of Clinical Microbiology. 59(2). 102 indexed citations

17.

Luk, Andrea O. Y., Hongjiang Wu, Eric S. H. Lau, et al.. (2020). Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001–2016: a retrospective study. Diabetologia. 64(1). 109–118. 25 indexed citations

18.

Lee, Nelson, Grace Lui, K. T. Wong, et al.. (2013). High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections. Clinical Infectious Diseases. 57(8). 1069–1077. 255 indexed citations

19.

Ngai, Shirley P.C., Alice Jones, C.W.Y. Hui-Chan, Fanny W.S. Ko, & David S.C. Hui. (2012). An Adjunct Intervention for Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). The Journal of Alternative and Complementary Medicine. 19(2). 178–181. 13 indexed citations

20.

Baddour, Larry M., Victor L. Yu, Keith P. Klugman, et al.. (2004). Combination Antibiotic Therapy Lowers Mortality among Severely Ill Patients with Pneumococcal Bacteremia. American Journal of Respiratory and Critical Care Medicine. 170(4). 440–444. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact